Showing results (241-250 of 255) with videos related to

Sort By:
Pageof 26
American Heart Journal|January 1, 1992
A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failureS D Katz, S H Kubo, M Jessup, et al.
Circulation|August 5, 1997
Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study GroupJ N Cohn, S Ziesche, R Smith, et al.
The New England Journal of Medicine|May 3, 2001
Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failureC W Yancy, M B Fowler, W S Colucci, et al.
American Journal of Hypertension|March 1, 1991
Reduced vascular compliance as a marker for essential hypertensionG E McVeigh, D E Burns, S M Finkelstein, et al.
Blood Pressure|March 1, 1993
Cardioreparation and the concept of modulating cardiovascular structure and functionK T Weber, C G Brilla, J G Cleland, et al.
American Heart Journal|August 1, 1985
A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term responseK Chatterjee, W W Parmley, J N Cohn, et al.
Circulation|May 1, 1987
Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrateJ N Cohn, D G Archibald, G S Francis, et al.
The New England Journal of Medicine|June 12, 1986
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative StudyJ N Cohn, D G Archibald, S Ziesche, et al.
The New England Journal of Medicine|December 17, 1998
A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial InvestigatorsJ N Cohn, S O Goldstein, B H Greenberg, et al.
The American Journal of Cardiology|January 15, 1990
Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failureM A Fifer, C R Molina, A C Quiroz, et al.
Pageof 26